UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Journal of thrombosis and haemostasis, 2021-08, Vol.19 (8), p.1874-1882

2021

Volltextzugriff (PDF)

Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Journal of thrombosis and haemostasis, 2021-04, Vol.19 (4), p.1112-1115

2021

Volltextzugriff (PDF)

Definition of major bleeding: Prognostic classification

Journal of thrombosis and haemostasis, 2020-11, Vol.18 (11), p.2852-2860

2020

Volltextzugriff (PDF)

Clinical history of cancer‐associated splanchnic vein thrombosis

Journal of thrombosis and haemostasis, 2021-04, Vol.19 (4), p.983-991

2021

Volltextzugriff (PDF)

Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non‐valvular atrial fibrillation and type 2 diabetes

Diabetes, obesity & metabolism, 2019-09, Vol.21 (9), p.2107-2114

2019

Volltextzugriff (PDF)

Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleeding

Journal of thrombosis and haemostasis, 2019-03, Vol.17 (3), p.499-506

2019

Volltextzugriff (PDF)

Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues

Journal of thrombosis and haemostasis, 2019-08, Vol.17 (8), p.1398-1399

2019

Volltextzugriff (PDF)

Reproductive issues in women on direct oral anticoagulants

Research and practice in thrombosis and haemostasis, 2021-05, Vol.5 (4), p.e12512-n/a, Article e12512

2021

Volltextzugriff (PDF)

Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation

Journal of thrombosis and haemostasis, 2020-07, Vol.18 (7), p.1562-1568

2020

Volltextzugriff (PDF)

What have we learned from real-world NOAC studies in venous thromboembolism treatment?

Thrombosis research, 2018-03, Vol.163, p.83-91

Beyer-Westendorf, Jan

2018

Volltextzugriff (PDF)

Comparative risk of major bleeding with rivaroxaban and warfarin: Population‐based cohort study of unprovoked venous thromboembolism

European journal of haematology, 2019-02, Vol.102 (2), p.143-149

2019

Volltextzugriff (PDF)

The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study

Journal of thrombosis and haemostasis, 2021-11, Vol.19 (11), p.2791-2800

2021

Volltextzugriff (PDF)

Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease

Research and practice in thrombosis and haemostasis, 2019-04, Vol.3 (2), p.207-216

2019

Volltextzugriff (PDF)

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis

Blood advances, 2022-08, Vol.6 (15), p.4516-4523

2022

Volltextzugriff (PDF)

Total intracranial hemorrhage volume measurement summating all compartments best in traumatic and nontraumatic intracranial bleeding

Brain and behavior, 2024-05, Vol.14 (5), p.e3481-n/a

2024

Volltextzugriff (PDF)

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Blood, 2014-08, Vol.124 (6), p.955-962

2014

Volltextzugriff (PDF)

Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA‐4: Time and Severity Matter Most

Stroke: vascular and interventional neurology, 2024-01, Vol.4 (1)

2024

Volltextzugriff (PDF)

Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism

Circulation (New York, N.Y.), 2014-01, Vol.129 (4), p.479-486

2014

Volltextzugriff (PDF)

Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry

Research and practice in thrombosis and haemostasis, 2022-10, Vol.6 (7), p.e12829-n/a, Article e12829

2022

Volltextzugriff (PDF)

Response to the Letter by Lucijanic et al., regarding our manuscript “Management and outcome of gastro-intestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs”

Journal of gastroenterology, 2017-09, Vol.52 (9), p.1077-1078

Beyer-Westendorf, Jan

2017

Volltextzugriff (PDF)

Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis

Critical care (London, England), 2022-06, Vol.26 (1), p.180-13, Article 180

2022

Volltextzugriff (PDF)

Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes

Research and practice in thrombosis and haemostasis, 2021-12, Vol.5 (8), p.e12604-n/a, Article e12604

2021

Volltextzugriff (PDF)

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study

Thrombosis and haemostasis, 2018-08, Vol.118 (8), p.1439-1449

2018

Volltextzugriff (PDF)

American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients

Blood advances, 2018-11, Vol.2 (22), p.3198-3225

2018

Volltextzugriff (PDF)

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin

Research and practice in thrombosis and haemostasis, 2021-02, Vol.5 (2), p.308-313

2021

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Aktive Filter

KollektionNexis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(257)
Mit Volltextzugriff
(207)

Publikationsform

Artikel
(272)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(255)
Deutsch
(25)
Japanisch
(13)
Norwegisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(177)
Life Sciences & Biomedicine
(174)
Humans
(122)
Cardiovascular System & Cardiology
(105)
Hematology
(105)
Peripheral Vascular Disease
(88)
Female
(72)
Male
(64)
Anticoagulants
(62)
Rivaroxaban
(53)
Aged
(52)
Middle Aged
(49)
Venous Thromboembolism
(46)
Anticoagulants - Therapeutic Use
(41)
Treatment Outcome
(39)
Anticoagulants - Adverse Effects
(37)
Bleeding
(36)
Prospective Studies
(35)
Aged, 80 And Over
(32)
Hemorrhage - Chemically Induced
(32)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Definition of major bleeding: Prognostic classification

Clinical history of cancer‐associated splanchnic vein thrombosis

Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non‐valvular atrial fibrillation and type 2 diabetes

Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleeding

Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues

Reproductive issues in women on direct oral anticoagulants

Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation

What have we learned from real-world NOAC studies in venous thromboembolism treatment?

Comparative risk of major bleeding with rivaroxaban and warfarin: Population‐based cohort study of unprovoked venous thromboembolism

The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study

Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis

Total intracranial hemorrhage volume measurement summating all compartments best in traumatic and nontraumatic intracranial bleeding

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA‐4: Time and Severity Matter Most

Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism

Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry

Response to the Letter by Lucijanic et al., regarding our manuscript “Management and outcome of gastro-intestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs”

Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis

Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study

American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin

Aktive Filter

Suchergebnisse filtern